Skip to main content

Dongwha Pharm.Co.,Ltd (000020.KS)

Boursa KuwaitView data quality →
51.8Fair

ValueMarkers Composite Index

Top 37%#28,305 of 44,707

DCF data not available

Piotroski
2/9
Weak
Beneish
-1.98
Investigate
Altman
1.04
Distress
DCF Value
-
N/A
ROIC
0.0%
Low
P/E
0.0
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Dongwha Pharm.Co.,Ltd (000020.KS) — VMCI valuation read

Dongwha Pharm.Co.,Ltd sits at VMCI 52/100, with the broad-market sample median at 50. That 2-point spread is the first thing to note on 000020.KS: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on 000020.KS are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on 000020.KS: 000020.KS trades at 16.0x earnings, 11% below the sector median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the sector median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of 0.6x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

000020.KS rose 1.4% over the trailing 7 days, with a +0.7% read on a 30-day basis.

Dongwha Pharm Co., Ltd. manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxant/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and teeth, hepatic protector, nutrient, tonic, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company was founded in 1897 and is based in Seoul, South Korea.

CEO: Doh Joon Yoon815 employeesKRwww.dong-wha.co.kr

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 000020.KS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.